We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Helix BioPharma Receives FDA IND Approval to Conduct a U.S. Phase I Clinical Study With L-DOS47

News   Feb 08, 2011

 
Helix BioPharma Receives FDA IND Approval to Conduct a U.S. Phase I Clinical Study With L-DOS47
 
 
 

RELATED ARTICLES

Are You A Super Pooper?

News

Fecal ‘super-donors’ can provide the necessary bacteria to restore gut chemicals that are lacking in illnesses like IBD and diabetes.

READ MORE

Energizing the Immune System to Eat Cancer

News

Immune cells called macrophages are supposed to serve and protect, but cancer has found ways to put them to sleep. Now researchers say they've identified how to fuel macrophages with the energy needed to attack and eat cancer cells.

READ MORE

Genetic Variant Tells the Story of Skin Color Evolution

News

A research team has conducted a genome-wide association study (GWAS) that provides novel insight into the evolution of variety in human skin color.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE